Trial
NCT02592395
Study of FOLFIRINOX Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
The University of Texas Health Science Center, Houston
Collaborators
—
Condition
Pancreatic Adenocarcinoma
Intervention
FOLFIRINOX
Why stopped
PI transferred to another institution and did not take this study with him.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-10-17